Press release
Nonalcoholic Steatohepatitis (NASH) Therapeutics Market: Insights and Strategic Imperatives
Nonalcoholic Steatohepatitis (NASH) Therapeutics Market
Get Exclusive PDF Sample Copy of Nonalcoholic Steatohepatitis Therapeutics Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=7691
Market Overview:
Nonalcoholic fatty liver disease (NAFLD) is a prevalent disorder characterized by excessive fat accumulation in the liver, often occurring in individuals who consume little to no alcohol. NAFLD can progress to NASH, a more severe condition marked by inflammation and irreversible liver damage.
The absence of FDA-approved drugs specifically for NASH treatment has spurred pharmaceutical companies to develop pipeline drugs targeting this silent liver disease. Factors such as the global rise in diabetes and obesity rates, coupled with increased awareness about available treatments, are driving market growth.
Key Insights:
Manufacturers are engaging in clinical trials, particularly for Elafibranor and other drugs aimed at reducing liver fat percentage, to enhance market credibility and launch innovative products.
Strategic initiatives such as mergers & acquisitions and research collaborations are crucial for market stakeholders to drive innovation and bring effective NASH treatments to market.
Opportunities and Challenges:
Opportunities lie in the rising prevalence of NASH globally and the urgent need for effective treatment options. However, challenges include poor diagnostics and a lack of proper diagnostic techniques hindering market growth.
Impact of COVID-19:
The pandemic has affected liver-related healthcare services, leading to a decline in therapy, detection, and follow-up of individuals with liver problems. Clinical trials for NASH drugs have also been disrupted due to delays in study launches.
Key Players and Developments:
Leading players in the NASH therapeutics market include Intercept Pharmaceuticals, Inc., GENFIT SA, Zydus Cadila, Conatus Pharmaceuticals, and Tobira Therapeutics, Inc., among others.
Recent developments such as licensing agreements and collaborations highlight efforts to expand access to NASH diagnostic tools and advance research in the field.
Regional Outlook:
North America dominates the NASH therapeutics market, driven by a high prevalence of NASH attributed to diabetes, obesity, and lifestyle changes.
Europe, particularly countries like Italy, Spain, Germany, the U.K., and France, presents lucrative opportunities for NASH therapeutics due to a high prevalence of the disease.
Recommendations:
Market stakeholders should focus on enhancing diagnostic capabilities and developing innovative therapies to address the unmet needs of NASH patients.
Collaboration with research institutions and regulatory bodies can expedite drug development and approval processes, facilitating market entry and expansion.
Buy this premium research report
https://www.transparencymarketresearch.com/checkout.php?rep_id=7691<ype=S
Explore More Trending Report by Transparency Market Research:
Dyspepsia Treatment Market
https://www.globenewswire.com/en/news-release/2023/03/10/2625158/0/en/Dyspepsia-Treatment-Market-to-advancement-at-a-CAGR-of-4-1-during-2022-2031-as-demand-for-non-invasive-treatment-is-growing-TMR-Study.html
Arthroscopic Visualisation Instrument Market
https://www.globenewswire.com/en/news-release/2023/03/10/2624906/0/en/Arthroscopic-Visualisation-Instrument-Market-to-Surpass-US-3-2-Bn-by-2031-As-Rise-in-Demand-for-Minimally-Invasive-Surgeries-TMR-Study.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nonalcoholic Steatohepatitis (NASH) Therapeutics Market: Insights and Strategic Imperatives here
News-ID: 3394100 • Views: …
More Releases from Transparency Market Research
Functional Coffee Market Expanding at 7.6% CAGR Through 2035 - By Product Type / …
The global functional coffee market was valued at US$ 21.5 Bn in 2024 and is projected to reach US$ 48.1 Bn by 2035, expanding at a compound annual growth rate (CAGR) of 7.6% from 2025 to 2035. This steady growth trajectory reflects the strong convergence of coffee consumption habits with rising demand for functional and wellness-oriented beverages. Functional coffee has transitioned from a niche category to a mainstream product offering,…
Global Electric Face Cleanser Market Poised for Robust Growth, projected to Reac …
The global electric face cleanser market is witnessing a transformative growth phase as consumers increasingly integrate advanced skincare technologies into their daily routines. Valued at USD 9.8 billion in 2025, the market is projected to expand significantly and reach USD 23.6 billion by 2036, growing at a healthy compound annual growth rate (CAGR) of 8.6% from 2026 to 2036. This growth trajectory underscores the rising importance of personal care technology,…
Asthma and COPD Drugs Market to Reach US$ 82.2 Billion by 2036, Growing at 5.7% …
The global asthma and COPD drugs market demonstrated strong fundamentals in 2025, with a valuation of US$ 44.7 Bn, reflecting the essential and recurring nature of respiratory therapeutics. Supported by a growing patient base and continuous pharmaceutical innovation, the market is projected to reach US$ 82.2 Bn by 2036, expanding at a compound annual growth rate (CAGR) of 5.7% from 2026 to 2036.
This growth trajectory highlights the increasing reliance on…
Low-Alcohol Beverages Market Outlook 2035: Global Industry Set to Expand from US …
The global low-alcohol beverages market is undergoing a structural transformation as consumers increasingly prioritize health, moderation, and mindful drinking without sacrificing taste or social experiences. Valued at US$ 2.1 billion in 2024, the market is projected to reach US$ 4.6 billion by 2035, expanding at a healthy CAGR of 7.5% from 2025 to 2035. This sustained growth reflects changing lifestyle preferences, generational shifts in alcohol consumption, and continuous innovation by…
More Releases for NASH
The Growing Demand For NASH Treatment Amid Obesity Epidemic: A Key Catalyst Acce …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Non-Alcoholic Steatohepatitis (NASH) Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for non-alcoholic steatohepatitis (NASH) has seen a considerable expansion in the past few years. Its value is expected to rise from $4.5 billion in 2024 to $6.06 billion in 2025, marking…
Nonalcoholic Steatohepatitis (NASH) Market Massive Growth opportunity Ahead
Introduction
Nonalcoholic Steatohepatitis (NASH) is an advanced form of nonalcoholic fatty liver disease (NAFLD) characterized by fat accumulation in the liver along with inflammation and liver cell damage. If left untreated, NASH can progress to fibrosis, cirrhosis, liver failure, or hepatocellular carcinoma. Closely tied to the global obesity and diabetes epidemic, NASH has become a major healthcare burden, with millions affected worldwide and no widely approved curative therapy to date.
The NASH…
Non Alcoholic Steatohepatitis (NASH) Market Size to Hit $21,879 Million by 2028 …
According to our experience research team, Non Alcoholic Steatohepatitis (NASH) Market was valued at USD 1,569 Million in 2021, and the global Non Alcoholic Steatohepatitis (NASH) industry is projected to reach a value of USD 21,879 Million by 2028, at a CAGR of 60.4% during the forecast period 2022-2028
The report is focused on gaining various Non Alcoholic Steatohepatitis (NASH) market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining…
NASH Market Insight and Landscape report
Report Snapshot:
NASH is one of the furthermost causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming years, with the disease affecting both adults and children. The epidemiology and demographic characteristics of NASH vary across different country level. Furthermore, individuals with NAFLD have a high frequency of metabolic comorbidities and could place a growing strain on health-care systems from their…
Nash releases debut EP 'She Don't Know'
London-based singer/songwriter Nash has released his debut EP She Don’t Know. Recorded at the legendary RAK Studios, She Don’t Know has the feel of 60s rock but with a modern twist, leaving the listener hooked throughout and wanting to come back for another listen. She Don’t Know’s leading single CK is an infectious number which is sure to be a hit for 2017.
Listening to the Beatles and Jack White growing…
Nash Technologies at GITEX/GULFCOMMS 2010
Harvey Nash subsidiary presents expert services to telecom operators in the Middle East, Africa and South Asia region
Nürnberg/Germany, 10th September 2010 – For the first time Nash Technologies will be present at GITEX/GULFCOMMS, the largest international trade event for mobile, fixed, IP and satellite communications for the Middle East, Africa and South Asia region, in Dubai from 17th to 21st October 2010 offering its telecom expert services. Nash Technologies will…
